同仁堂科技(01666.HK)全年歸母淨利上升11.95%至4.68億元 擬每股派息0.16元
格隆匯 3 月 28日丨同仁堂科技(01666.HK)發佈全年業績公吿,截至2020年12月31日止年度,集團收入為人民幣460,736.9萬元,較上年同期上升2.92%;實現淨利潤為人民幣78,650.7萬元,較上年同期上升6.09%;公司所有者應占淨利潤為人民幣46,755.3萬元,較上年同期上升11.95%;每股收益為人民幣0.37元;每股股息為人民幣0.16元。
報吿期內,集團始終關注市場變化,聚焦市場需求,積極探索疫情防控常態化下的生產經營思路,利用新建生產基地產能優勢,將疫情防控與穩定生產經營緊密結合,全力保障產品供應、拉動產品銷售,整體業績恢復性增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.